Patient Characteristics in BCG vs. Gemcitabine/Docetaxel Groups In an international study involving 299 patients with BCG-unresponsive NMIBC across 10 centers, 204 patients received additional BCG ...

Gemcitabine is under clinical development by Johnson & Johnson and currently in Phase III for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer). According to GlobalData, Phase ...

Gemcitabine is a small molecule commercialized by Johnson & Johnson, with a leading Phase III program in Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer). According to ...

What are the side effects of gemcitabine and nab-paclitaxel? Side effects can vary from person to person. They also depend on what other treatments you're having. When to contact your team Your doctor ...

Prior to induction BCG, the gemcitabine-docetaxel group had a significantly higher proportion of patients with Ta/Tis (noninvasive) tumors compared with the BCG group (68.8% vs 52.2%), whereas the ...

WASHINGTON, DC—Sequential intravesical gemcitabine-docetaxel (Gem-Doce) for treatment-naïve high-risk nonmuscle-invasive bladder cancer (HR-NMIBC) achieves oncologic outcomes comparable to ...

Intra-arterial administration of gemcitabine conferred a median PFS benefit of 8 months when compared with standard of care for patients with locally advanced pancreatic cancer, according to ...

Transcription: 0:08 | We presented the top-line results, which included the overall survival, which was statistically significantly improved in the group of patients who've got NALIRIFOX over ...

Gemcitabine chemotherapy is used for advanced cancers of the breast, lungs, ovaries, and pancreas. Learn about delivery, side effects, effectiveness, and more.

No. Gemcitabine plus nab-paclitaxel represents one of the gold-standard regimens used in the first-line treatment setting for metastatic pancreatic ductal adenocarcinoma. E. Gabriela Chiorean This ...

Gemcitabine belongs to pyrimidine analogs, which require stepwise phosphorylation to the respective triphosphate metabolites to exert their pharmacological activity: gemcitabine is phosphorylated to ...